Funding news
Shenzhen TargetRx, Inc. logo

Shenzhen TargetRx, Inc. Secures $50 Million in Series C Funding for Groundbreaking Cancer Therapies

Recently funded · $50.0M Series cPharmaceutical

Get the full Shenzhen TargetRx, Inc. company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Shenzhen TargetRx, Inc. has successfully secured an impressive $50 million in funding, a significant boost for the clinical stage pharmaceutical R&D company dedicated to revolutionizing cancer treatment. TargetRx specializes in developing next-generation targeted therapies, particularly for cancer patients who have become resistant or refractory to existing therapies. By leveraging cutting-edge and efficient small molecule drug discovery platforms, the company has established itself as a leader in innovative research and development, marked by an extensive portfolio of over 170 patents across major global markets, including China, the US, Europe, and Japan. This recent funding will primarily enhance TargetRx's capabilities in drug design, screening, and optimization, enabling the continued advancement of several promising compounds currently undergoing multi-national clinical trials. The capital will also be directed toward accelerating the development timeline of these therapies, aiming to address the unmet medical needs of cancer patients worldwide. With a commitment to excellence and groundbreaking advancements in oncology, TargetRx is poised to make a substantial impact on how cancer is treated, paving the way for more effective and personalized solutions for patients in desperate need of new options. For further inquiries about partnerships or the technology, please reach out to BD contact Shujun Mai at shujun.mai@tjrbiosciences.com.

Other recently funded companies

View all

Other recent Series c rounds

Companies that recently closed a Series c round.

#CompanyAmount
1
HyperLight logo

HyperLight

United States

$80.0M
2
Gradial logo

Gradial

United States

$65.0M
3
Embroker logo

Embroker

United States

$100.0M
4
Havenly Brands (Havenly, Interior Define, Burrow, The Citizenry, The Inside, and St. Frank) logo

Havenly Brands (Havenly, Interior Define, Burrow, The Citizenry, The Inside, and St. Frank)

United States

$28.0M
5
Lilac Infotech logo

Lilac Infotech

India

$145.0M